Müller B, Garn H, Hochscheid R
Laboratory of Respiratory Cell Biology, Department of Internal Medicine, Philipps University of Marburg, 35033 Marburg, Germany.
Thorax. 2003 Feb;58(2):127-34. doi: 10.1136/thorax.58.2.127.
Surfactant synthesis and secretion has been shown to be impaired in type II cells from diseased lungs. The mechanism of surfactant lipid recycling, which is an important physiological process in surfactant treatment, was studied in type II cells isolated from injured lungs.
Different stages of lung injury were induced by exposing rats to 10 ppm nitrogen dioxide (NO(2)) for 3, 20, and 28 days. Type II cells were isolated from these lungs and recycling of (3)H-DPPC labelled surfactant-like liposomes was studied in vitro.
Uptake of liposomes (150 micro g/ml) for 20 minutes in the absence and presence of surfactant protein-A (SP-A, 5 micro g/ml) was higher in cells from NO(2) injured lungs (63-78%) than in control cells. There was no difference in liposome uptake between the groups with NO(2) exposure of different duration. After liposome uptake, most of the internalised label remained in the phosphatidylcholine (PC) fraction and increased with duration of exposure to NO(2). After 20 minutes internalisation, cells were allowed to resecrete lipids for a further 20 minute period. In cells from controls and from all stages of lung injury, liposomes that had been internalised in the presence of SP-A were resecreted to a greater extent than those internalised without SP-A. However, cells from lungs exposed to NO(2) resecreted less lipid than cells from control lungs. Again, there was no difference in resecretion between the groups with NO(2) exposure of different duration.
Type II cells from injured lungs internalise more surfactant-like liposomes than cells from controls, suggesting a putative therapeutic significance to cope with limited alveolar surfactant pools in lung injury.
已表明患病肺脏的II型细胞中表面活性剂的合成和分泌受损。在从受损肺脏分离的II型细胞中研究了表面活性剂脂质再循环的机制,这是表面活性剂治疗中的一个重要生理过程。
通过将大鼠暴露于10 ppm二氧化氮(NO₂)3天、20天和28天来诱导不同阶段的肺损伤。从这些肺脏中分离出II型细胞,并在体外研究³H-DPPC标记的表面活性剂样脂质体的再循环。
在不存在和存在表面活性剂蛋白A(SP-A,5 μg/ml)的情况下,NO₂损伤肺脏的细胞对脂质体(150 μg/ml)20分钟的摄取率(63%-78%)高于对照细胞。不同暴露时长的NO₂组之间脂质体摄取没有差异。摄取脂质体后,大部分内化标记物保留在磷脂酰胆碱(PC)部分,并随NO₂暴露时间延长而增加。内化20分钟后,让细胞再分泌脂质20分钟。在对照细胞和所有肺损伤阶段的细胞中,在SP-A存在下内化的脂质体比在没有SP-A时内化的脂质体再分泌程度更大。然而,暴露于NO₂的肺脏的细胞再分泌的脂质比对照肺脏的细胞少。同样,不同暴露时长的NO₂组之间再分泌没有差异。
与对照细胞相比,受损肺脏的II型细胞内化更多的表面活性剂样脂质体,这表明在应对肺损伤中有限的肺泡表面活性剂储备方面具有潜在的治疗意义。